U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501702) titled 'A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis' on March 24.
Brief Summary: The purpose of this study is to evaluate the pharmacodynamic (PD) effect, safety, and tolerability of Povetacicept in participants with generalized myasthenia gravis (gMG).
Study Start Date: April 16
Study Type: INTERVENTIONAL
Condition:
Myasthenia Gravis, Generalized
Intervention:
DRUG: Povetacicept
Solution for Subcutaneous Injection.
DRUG: Placebo
Solution for Subcutaneous Injection.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Vertex Pharmaceuticals Incorporated
Published by HT Digital Content Servic...